Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-23-001442
Filing Date
2023-02-14
Accepted
2023-02-14 17:28:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 arrowmark-vktx123122a5.htm SC 13G/A 52567
  Complete submission text file 0001172661-23-001442.txt   54166
Mailing Address 100 FILLMORE STREET, SUITE 325 DENVER CO 80206
Business Address 100 FILLMORE STREET, SUITE 325 DENVER CO 80206 303.398.2929
ArrowMark Colorado Holdings LLC (Filed by) CIK: 0001483859 (see all company filings)

EIN.: 392068140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Subject) CIK: 0001607678 (see all company filings)

EIN.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88828 | Film No.: 23632002
SIC: 2834 Pharmaceutical Preparations